| 1W72 | D:1-179; D:1-179 | CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 |
| 1JF1 | A:1-179 | CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A DECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A |
| 1JHT | A:1-179 | CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH A NONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. |
| 1LP9 | H:1-179; H:1-179 | XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 |
| 1OGA | A:1-179 | A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION. |
| 1P7Q | A:1-179 | CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-1, A HOST AND VIRAL MHC RECEPTOR |
| 1QEW | A:1-179 | HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATED ANTIGEN 3 (RESIDUES 271-279) |
| 1QR1 | D:1-179; D:1-179 | POOR BINDING OF A HER-2/NEU EPITOPE (GP2) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE |
| 1QRN | A:1-179 | CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A |
| 1QSF | A:1-179 | STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A |
| 1S8D | A:1-179 | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A |
| 1S9W | A:1-179 | CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC, IN COMPLEX WITH HLA-A2 |
| 1S9Y | A:1-179 | CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE, SLLMWITQS, IN COMPLEX WITH HLA-A2 |
| 1T1W | A:1-179 | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V |
| 1T1X | A:1-179 | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L |
| 1T1Y | A:1-179 | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V |
| 1T1Z | A:1-179 | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A |
| 1T20 | A:1-179 | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I |
| 1T21 | A:1-179 | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINIC CRYSTAL |
| 1T22 | A:1-179 | STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDE VARIANTS BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, ORTHORHOMBIC CRYSTAL |
| 1TVH | D:1-179; D:1-179 | CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2 |
| 2JCC | H:1-179; H:1-179 | AH3 RECOGNITION OF MUTANT HLA-A2 W167A |
| 2P5E | A:1-179 | CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY |
| 2P5W | A:1-179 | CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY |
| 2UWE | H:1-179; H:1-179 | LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION |
| 2V2W | D:1-179; D:1-179 | T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT |
| 2V2X | D:1-179; D:1-179 | T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT. |
| 2VLJ | A:1-179 | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
| 2VLK | A:1-179 | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
| 2VLL | D:1-179; D:1-179 | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
| 2VLR | F:1-179; F:1-179 | THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN |
| 2X4N | D:1-178; D:1-178 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT |
| 2X4O | D:1-179; D:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120-128 |
| 2X4P | D:1-179; D:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE |
| 2X4Q | D:1-179; D:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE |
| 2X4R | D:1-179; D:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE |
| 2X4S | D:1-179; D:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN |
| 2X4T | D:1-179; D:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE |
| 2X70 | D:1-178; D:1-178 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE PEPTIDE |
| 3KLA | D:1-179; D:1-179 | CA2+ RELEASE FROM THE ENDOPLASMIC RETICULUM OF NY-ESO-1 SPECIFIC T CELLS IS MODULATED BY THE AFFINITY OF T CELL RECEPTOR AND BY THE USE OF THE CD8 CO-RECEPTOR |
| 3MGO | J:1-179; J:1-179; J:1-179; J:1-179 | CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 |
| 3MGT | J:1-179; J:1-179; J:1-179; J:1-179 | CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201 |
| 3MR9 | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE M5A VARIANT |
| 3MRB | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT |
| 3MRC | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT |
| 3MRD | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT |
| 3MRE | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE |
| 3MRF | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT |
| 3MRG | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE |
| 3MRH | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT |
| 3MRI | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT |
| 3MRJ | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT |
| 3MRK | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE |
| 3MRL | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT |
| 3MRM | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE |
| 3MRN | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS4B-1807-1816 DECAPEPTIDE |
| 3MRO | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT |
| 3MRP | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT |
| 3MRQ | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN-A MART1 DECAPEPTIDE VARIANT |
| 3MRR | A:1-179 | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE |
| 3MYJ | D:1-179; D:1-179 | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT. |
| 3O3A | D:1-179; D:1-179 | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1 |
| 3O3B | D:1-179; D:1-179 | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1 |
| 3O3D | D:1-179; D:1-179 | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2 |
| 3O3E | D:1-179; D:1-179 | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1 |
| 3PWJ | D:1-179; D:1-179 | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT |
| 3PWL | D:1-179; D:1-179 | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE |
| 3PWN | D:1-179; D:1-179 | HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT |
| 3PWP | A:1-179 | THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE |
| 3QDG | A:1-179 | THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE |
| 3QDJ | A:1-179 | THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE |
| 3QDM | A:1-179 | THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE |
| 3QEQ | A:1-179 | THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE |
| 2XPG | A:1-179 | CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX |
| 1Q94 | D:1-179; D:1-179 | STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE |
| 1QVO | D:1-179; D:1-179 | STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANT NONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THE PRESENCE OF A MIDDLE ANCHOR RESIDUE |
| 1X7Q | A:1-179 | CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSID PEPTIDE |
| 3QZW | D:1-179; D:1-179 | PLASTICITY OF HUMAN CD8 BINDING TO PEPTIDE-HLA-A*2402 |
| 1TMC | A:1-175 | THE THREE-DIMENSIONAL STRUCTURE OF A CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE MISSING THE ALPHA3 DOMAIN OF THE HEAVY CHAIN |
| 1M05 | C:1-179; C:1-179 | HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT |
| 1XR8 | A:1-179 | CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 |
| 1XR9 | A:1-179 | CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDES FROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 |
| 1JGD | A:1-179 | HLA-B*2709 BOUND TO DECA-PEPTIDE S10R |
| 1JGE | A:1-179 | HLA-B*2705 BOUND TO NONA-PEPTIDE M9 |
| 1K5N | A:1-179 | HLA-B*2709 BOUND TO NONA-PEPTIDE M9 |
| 1OF2 | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VIPR) PEPTIDE (RESIDUES 400-408) |
| 1UXW | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS |
| 1W0V | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 |
| 1W0W | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF-RESPONSE FACTOR 1 |
| 3LV3 | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521) |
| 1XH3 | A:1-179 | CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERIC PEPTIDES IN COMPLEX WITH HLA-B*3501 |
| 1ZHK | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY |
| 1ZHL | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING 13-MER EBV ANTIGEN LPEPLPQGQLTAY |
| 1ZSD | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBV ANTIGEN EPLPQGQLTAY |
| 2NW3 | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*3508 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A |
| 2NX5 | Q:1-179; Q:1-179; Q:1-179; Q:1-179 | CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A |
| 3KWW | A:1-179 | CRYSTAL STRUCTURE OF THE 'RESTRICTION TRIAD' MUTANT OF HLA B*3508, BETA-2-MICROGLOBULIN AND EBV PEPTIDE |
| 3KXF | K:1-179; K:1-179; K:1-179; K:1-179 | CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER |
| 3LKN | A:1-179 | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1918 STRAIN |
| 3LKO | A:1-179 | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1934 STRAIN |
| 3LKP | A:1-179 | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1972 STRAIN |
| 3LKR | A:1-179 | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 2009 H1N1 SWINE ORIGIN STRAIN |
| 3LKS | A:1-179 | CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN |
| 3MV8 | A:1-179 | CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA-B*3501/HPVG |
| 3MV9 | A:1-179 | CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA-B*3501/HPVG |
| 3LN4 | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2 |
| 3LN5 | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE |
| 1M6O | A:1-179 | CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLA DPA*0201 PEPTIDE |
| 1SYS | A:1-179 | CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY |
| 1SYV | A:1-179 | HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF |
| 3KPL | A:1-179 | CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN |
| 3KPM | A:1-179 | CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE |
| 3KPN | A:1-179 | CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN |
| 3KPO | A:1-179 | CRYSTAL STRUCTURE OF HLA B*4403 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE |
| 3KPP | A:1-179 | CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN |
| 3KPQ | A:1-179 | CRYSTAL STRUCTURE OF HLA B*4405 IN COMPLEX WITH EEYLKAWTF, A MIMOTOPE |
| 3KPR | F:1-179; F:1-179 | CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE |
| 3L3D | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 3L3G | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 3L3J | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE F3A/R5A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 3L3K | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*4402 IN COMPLEX WITH THE R5A/F7A DOUBLE MUTANT OF A SELF-PEPTIDE DERIVED FROM DPA*0201 |
| 2RFX | A:1-179 | CRYSTAL STRUCTURE OF HLA-B*5701, PRESENTING THE SELF PEPTIDE, LSSPVTKSF |
| 1QQD | A:2-179 | CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR |
| 1ONQ | C:7-181; C:7-181 | CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE |
| 1XZ0 | C:8-181; C:8-181 | CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETIC MYCOBACTIN LIPOPEPTIDE |
| 1L8J | A:53-177 | CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR AND BOUND PHOSPHOLIPID MOLECULE |
| 1LQV | B:53-180; B:53-180 | CRYSTAL STRUCTURE OF THE ENDOTHELIAL PROTEIN C RECEPTOR WITH PHOSPHOLIPID IN THE GROOVE IN COMPLEX WITH GLA DOMAIN OF PROTEIN C. |
| 3JTC | B:53-180; B:53-180 | IMPORTANCE OF MG2+ IN THE CA2+-DEPENDENT FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID DOMAINS OF VITAMIN K-DEPENDENT CLOTTING AND ANTICLOTTING PROTEINS |
| 3M17 | G:5-174; G:5-174; G:5-174; G:5-174 | CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE INHIBITOR |
| 3M1B | G:5-174; G:5-174; G:5-174; G:5-174 | CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR |
| 1KPR | C:1-179; C:1-179 | THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E |
| 1KTL | C:1-179; C:1-179 | THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E |
| 1MHE | C:2-179; C:2-179 | THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E |
| 1YDP | A:2-179 | 1.9A CRYSTAL STRUCTURE OF HLA-G |
| 3KYN | A:2-179 | CRYSTAL STRUCTURE OF HLA-G PRESENTING KGPPAALTL PEPTIDE |
| 1JE6 | A:1-178 | STRUCTURE OF THE MHC CLASS I HOMOLOG MICB |
| 1KCG | C:9-185 | NKG2D IN COMPLEX WITH ULBP3 |
| 3O4L | A:1-179 | GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS |
| 1T7W | A:6-181 | ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 400 |
| 1T7X | A:6-181 | ZN-ALPHA-2-GLYCOPROTEIN; REFOLDED CHO-ZAG PEG 400 |
| 1T7Y | A:6-181 | ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG PEG 200, NO GLYCEROL |
| 1T7Z | A:6-181 | ZN-ALPHA-2-GLYCOPROTEIN; BACULO-ZAG NO PEG, NO GLYCEROL |
| 1T80 | A:6-181 | ZN-ALPHA-2-GLYCOPROTEIN; CHO-ZAG PEG 200 |
| 1ZAG | D:6-181; D:6-181; D:6-181; D:6-181 | HUMAN ZINC-ALPHA-2-GLYCOPROTEIN |
)
)